The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank Regs Regulatory News (AXB)

Share Price Information for Axis Bank Regs (AXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 71.60
Bid: 71.20
Ask: 71.60
Change: 0.00 (0.00%)
Spread: 0.40 (0.562%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 71.60
AXB Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notes Allotment Intimation

8 Sep 2021 14:17

RNS Number : 1559L
Axis Bank Limited
08 September 2021
 

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED

STATES OF AMERICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL

 

AXIS/CO/CS/274/2021-22

 

September 8, 2021

Dear Sir(s),

 

Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the "Listing Regulations")

 

This is with reference to our letter no. AXIS/CO/CS/251/2021-22 dated August 30, 2021, wherein we had informed that the Bank has initiated the process of issuing of the debt instruments in the form of the Additional Tier 1 Notes in foreign currency, subject to market conditions. We also refer to our letter no. AXIS/CO/CS/262/2021-22 dated September 2, 2021, wherein we had informed that the Bank, acting through its GIFT City branch, has completed the pricing of its U.S. dollar denominated Basel III compliant Additional Tier 1 Notes (the "Notes").

 

We are pleased to inform that the Bank has raised USD 600,000,000 through the issue and allotment of USD denominated, unsecured, 4.10% Basel III compliant, Additional Tier 1 Notes (i) to qualified institutional buyers (as defined in Rule 144A under the United States Securities Act of 1933, as amended (the "U.S. Securities Act")) and (ii) outside the United States in offshore transactions in compliance with Regulation S under the U.S. Securities Act.

 

The Notes will be listed on Singapore Exchange Limited, International Securities Market, India International Exchange (IFSC) Limited and the NSE IFSC Limited (NSE International Exchange).

 

This is for information of all concerned, in compliance with the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

 

Thanking you,

 

Yours sincerely,

For Axis Bank Limited

 

 

 

Girish V. Koliyote

Company Secretary

 

DISCLAIMER

 

The Offering Circular ("OC") for the GMTN programme has not been and will not be registered or filed or published as a prospectus or a statement in lieu of a prospectus with the Registrar of Companies ("RoC"), the Securities and Exchange Board of India ("SEBI") or any other statutory or regulatory body of like nature in India in respect of a public offer or information memorandum or other offering material in respect of any private placement of securities under the Companies Act, 2013, as amended, and the rules framed thereunder or any other applicable Indian laws.

 

The OC has not been and will not be reviewed or approved by any regulatory authority in India, including, but not limited to, the SEBI, the RoC, the Reserve Bank of India, or any stock exchange in India. This OC and the Additional Tier 1 Notes ("Notes") are not and should not be construed as an advertisement, invitation, offer or sale of any securities to the public or any person resident in India.

 

The Notes have not been and will not be, offered or sold to any person resident in India.

 

This information relates to an offering of the Notes to be offered and sold (i) to qualified institutional buyers (as defined in Rule 144A under the United States Securities Act of 1933, as amended (the "U.S. Securities Act")) and (ii) outside the United States in offshore transactions in compliance with Regulation S under the U.S. Securities Act. This information is not an offer of securities for sale in the United States. The Notes referred to herein have not been and will not be registered under the U.S. Securities Act or the laws of any state of the United States or elsewhere and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws of the United States. There is no intention to register any portion of any offering in the United States or to conduct a public offering of securities in the United States or in any other jurisdiction. Nothing in this communication shall constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction in which such offer or sale would be unlawful. No money, securities or other consideration is being solicited by this announcement or the information contained herein and, if sent in response to this announcement or the information contained herein, will not be accepted.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEADNPEFLFEFA
Date   Source Headline
8th Jul 20192:22 pmRNSALLOTMENT OF EQUITY SHARES UNDER ESOP - QUARTERLY
5th Jul 20192:41 pmRNSBOARD MEETING OF AXIS BANK LIMITED
4th Jun 20193:06 pmRNSREVISION OF CREDIT RATING ASSIGNED BY FITCH RATING
23rd May 20191:05 pmRNSAppointment and Re-Appointment of Directors
25th Apr 20195:10 pmRNSOUTCOME OF THE BOARD MEETING OF AXIS BANK LIMITED
26th Mar 20192:04 pmRNSQUARTERLY ALLOTMENT OF EQUITY SHARES UNDER ESOP
13th Mar 20197:29 amRNSAppointment Of Shri Rakesh Makhija As The Chairman
30th Jan 201912:49 pmRNS3rd Quarter Results
31st Dec 201812:11 pmRNSCHANGE IN MANAGING DIRECTOR & CEO OF THE BANK
31st Dec 201811:55 amRNSQUARTERLY REPORTING ALLOT OF EQ SHARES UNDER ESOP
28th Dec 201811:40 amRNSSENIOR UNSECURED REDEEMABLE NCD
21st Dec 20181:25 pmRNSRETIREMENT OF V SRINIVASAN AS DMD OF THE BANK
10th Dec 20187:17 amRNSREAPPOINTMENT OF INDEPENDENT DIRECTORS
10th Dec 20187:05 amRNSAPPOINTMENT OF AMITABH CHAUDHRY AS THE MD & CEO
2nd Nov 20181:23 pmRNSRESULTS FOR THE QUARTER ENDED 30TH SEPTEMBER 2018
2nd Nov 201812:43 pmRNSAppointment Of Amitabh Chaudhry As Designated MD
2nd Nov 201812:22 pmRNSDirectorate Change
17th Oct 20188:05 amRNSAXIS BANK RAISES USD 50 MILLION
8th Oct 20181:25 pmRNSDirector Declaration - CESSATION
5th Oct 20189:22 amRNSPublication of Offering Circular -1 October 2018
24th Sep 20182:07 pmRNSQUARTERLY REPORTING ALLOT OF EQ SHARES UNDER ESOP
24th Sep 20182:04 pmRNSNotice of Results
10th Sep 20187:05 amRNSRBI APPROVAL FOR APPOINTMENT OF MD & CEO
30th Jul 20182:03 pmRNS1st Quarter Results
27th Jun 20181:05 pmRNSQuarterly Reporting - Allotment of Equity shares
16th May 201810:36 amRNSResult of Meeting
26th Apr 20183:16 pmRNSApproval for Grant of Stock Options
26th Apr 20182:52 pmRNSAnnual Financial Results
9th Apr 20183:04 pmRNSRegulation 30 of SEBI (LODR) Requirements, 2018
28th Mar 20189:44 amRNSESOP Allotment details
22nd Jan 20189:06 amRNS3rd Quarter Results
10th Jan 20181:11 pmRNSQUARTERLY REPORTING - ALLOT. OF EQ. SH. UNDER ESOP
20th Dec 20171:51 pmRNSNotice of Results
19th Dec 20177:00 amRNSAPPOINTMENT OF ADDITIONAL NON-EXECUTIVE DIRECTOR
18th Dec 20171:59 pmRNSIssue of Equity
8th Dec 201711:46 amRNSReappointment of MD & CEO
8th Dec 201711:40 amRNSOutcome of EGM
14th Nov 20178:37 amRNSNotice of Extraordinary General Meeting
10th Nov 20171:20 pmRNSPress release - Raising of Funds
10th Nov 201711:51 amRNSOutcome of Board Meeting - Raising of Funds
7th Nov 20172:52 pmRNSNotice of Board Meeting - Raising of Funds
17th Oct 201712:09 pmRNSHalf-year Results
11th Oct 20172:08 pmRNSDirectorate Change - CESSATION
6th Oct 20174:00 pmRNSDISCLOSURE IN TERMS OF REGULATION 30 OF SEBI LODR
26th Sep 201710:54 amRNSQUARTERLY REPORTING - ALLOT. OF SHARES UNDER ESOP
14th Sep 201712:18 pmRNSNotice of Results
1st Sep 20177:00 amRNSInformation on Bank's exposure to select accounts
3rd Aug 20179:56 amRNSFinal Terms for issue of 500,000,000 Notes
31st Jul 201712:24 pmRNSPublication of Offering Circular - 28 July 2017
31st Jul 201711:52 amRNSAnnual Report for the Financial Year 2016-17

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.